Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases

Digestive and Liver Disease

Volumn 37, Issue 8, 2005, Pages 584-592

  Gao, Q ^a   Meijer, M J W ^a   Kubben, F J G M ^a   Sier, C F M ^a   Kruidenier, L ^a   van Duijn, W ^a   van den Berg, M ^a   van Hogezand, R A ^a   Lamers, C B H W ^a   Verspaget, H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Inflammatory bowel disease; Matrix metalloproteinase

Indexed keywords

GELATINASE A; GELATINASE B; MESSENGER RNA; PRIMER DNA;

ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; ENTERITIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE RESECTION; MAJOR CLINICAL STUDY; NEUTROPHIL; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBMUCOSA; ULCERATIVE COLITIS; ZYMOGRAPHY; ADULT; AGED; BASEMENT MEMBRANE; CASE CONTROL STUDY; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENETICS; HOSPITALIZATION; INTESTINE; MALE; METABOLISM; MIDDLE AGED;

ADULT; AGED; BASEMENT MEMBRANE; CASE-CONTROL STUDIES; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEUTROPHILS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 28844444682     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.02.011     Document Type: Article

References (43)

1. Kirsner J.B. The historical basis of the idiopathic inflammatory bowel diseases. Inflamm Bowel Dis 1 (1995) 2-26
2. Fiocchi C. Inflammatory bowel disease: dogmas and heresies. Dig Liver Dis 34 (2002) 306-311
3. Parsons S.L., Watson S.A., Brown P.D., Collins H.M., and Steele R.J. Matrix metalloproteinases. Br J Surg 84 (1997) 160-166
4. Shapiro S.D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr Opin Cell Biol 10 (1998) 602-608
5. Shapiro S.D., and Senior R.M. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol 20 (1999) 1100-1102
6. Nagase H., and Woessner Jr. J.F. Matrix metalloproteinases. J Biol Chem 274 (1999) 21491-21494
7. Brinckerhoff C.E., and Matrisian L.M. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3 (2002) 207-214
8. McCawley L.J., and Matrisian L.M. Matrix metalloproteinases: they're not just for matrix anymore!. Curr Opin Cell Biol 13 (2001) 534-540
9. Vincenti M.P. The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods Mol Biol 151 (2001) 121-148
10. Yu A.E., Murphy A.N., and Stetler-Stevenson W.G. 72-kDa gelatinase (gelatinase A): structure, activation, regulation and substrate specificity. In: Parks W.P., and Mecham R.P. (Eds). Matrix metalloproteinases (1998), Academic Press, San Diego 85-113
11. Hibbs M.S., Hasty K.A., Seyer J.M., Kang A.H., and Mainardi C.L. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260 (1985) 2493-2500
12. Shapiro S.D., Kobayashi D.K., Pentland A.P., and Welgus H.G. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J Biol Chem 268 (1993) 8170-8175
13. Pender S.L., McKenzie C., Shaida A., and MacDonald T.T. Regulation of matrix metalloproteinases in human intestinal mucosa. Ann N Y Acad Sci 878 (1999) 581-582
14. Pender S.L., Tickle S.P., Docherty A.J., Howie D., Wathen N.C., and MacDonald T.T. A major role for matrix metalloproteinases in T cell injury in the gut. J Immunol 158 (1997) 1582-1590
15. Kubben F.J.G.M., Heerding M.M., Sier C.F.M., van Hogezand R.A., Wagtmans M.J., Lamers C.B.W.H., et al. Assessment of the matrix metalloproteinases gelatinase A and B in intestinal tissue of patients with inflammatory bowel disease. Gastroenterology 110 (1996) A943
16. Bailey C.J., Hembry R.M., Alexander A., Irving M.H., Grant M.E., and Shuttleworth C.A. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J Clin Pathol 47 (1994) 113-116
17. Baugh M.D., Evans G.S., Hollander A.P., Davies D.R., Perry M.J., Lobo A.J., et al. Expression of matrix metalloproteases in inflammatory bowel disease. Ann N Y Acad Sci 859 (1998) 249-253
18. Baugh M.D., Perry M.J., Hollander A.P., Davies D.R., Cross S.S., Lobo A.J., et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 117 (1999) 814-822
19. von Lampe B., Barthel B., Coupland S.E., Riecken E.O., and Rosewicz S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47 (2000) 63-73
20. Stallmach A., Chan C.C., Ecker K.W., Feifel G., Herbst H., Schuppan D., et al. Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis. Gut 47 (2000) 415-422
21. Matsuno K., Adachi Y., Yamamoto H., Goto A., Arimura Y., Endo T., et al. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis. J Gastroenterol 38 (2003) 348-354
22. Kirkegaard T., Hansen A., Bruun E., and Brynskov J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 53 (2004) 701-709
23. Kruidenier L., Kuiper I., Van Duijn W., Marklund S.L., van Hogezand R.A., Lamers C.B., et al. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease. J Pathol 201 (2003) 7-16
24. Kuyvenhoven J.P., Van Hoek B., Blom E., Van Duijn W., Hanemaaijer R., Verheijen J.H., et al. Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma. Thromb Haemost 89 (2003) 718-725
25. Kuyvenhoven J.P., Verspaget H.W., Gao Q., Ringers J., Smit V.T., Lamers C.B., et al. Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection. Transplantation 77 (2004) 1646-1652
26. Sier C.F., Kubben F.J., Ganesh S., Heerding M.M., Griffioen G., Hanemaaijer R., et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 74 (1996) 413-417
27. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
28. Matrisian L.M. Matrix metalloproteinase gene expression. Ann N Y Acad Sci 732 (1994) 42-50
29. Fini M.E., Cook J.R., Mohan R., and Brinckerhoff C.E. Regulation of matrix metalloproteinase gene expression. In: Parks W.C., and Mecham R.P. (Eds). Matrix metalloproteinase (1998), Academic Press, San Diego 299-356
30. Agren M.S. Gelatinase activity during wound healing. Br J Dermatol 131 (1994) 634-640
31. Pender S.L., Salmela M.T., Monteleone G., Schnapp D., McKenzie C., Spencer J., et al. Ligation of α4β1 integrin on human intestinal mucosal mesenchymal cells selectively up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. Am J Pathol 157 (2000) 1955-1962
32. McKaig B.C., McWilliams D., Watson S.A., and Mahida Y.R. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease. Am J Pathol 162 (2003) 1355-1360
33. Stetler-Stevenson W.G. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest 103 (1999) 1237-1241
34. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17 (2001) 463-516
35. Corcoran M.L., Hewitt R.E., Kleiner Jr. D.E., and Stetler-Stevenson W.G. MMP-2: expression, activation and inhibition. Enzyme Protein 49 (1996) 7-19
36. Levi E., Fridman R., Miao H.Q., Ma Y.S., Yayon A., and Vlodavsky I. Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. Proc Natl Acad Sci USA 93 (1996) 7069-7074
37. McQuibban G.A., Gong J.H., Tam E.M., McCulloch C.A., Clark-Lewis I., and Overall C.M. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 289 (2000) 1202-1206
38. Schuppan D., and Hahn E.G. MMPs in the gut: inflammation hits the matrix. Gut 47 (2000) 12-14
39. Beck P.L., and Podolsky D.K. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5 (1999) 44-60
40. Kruidenier L., Kuiper I., Van Duijn W., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 201 (2003) 17-27
41. Delclaux C., Delacourt C., D'Ortho M.P., Boyer V., Lafuma C., and Harf A. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am J Respir Cell Mol Biol 14 (1996) 288-295
42. Gao Q., van der Zon J.M., Van Duijn W., Meijer M.J.W., van Hogezand R.A., Lamers C.B.H.W., et al. Leucocyte matrix metalloproteinase (MMP)-9 gene and protein regulation in Crohn's disease. Gastroenterology 124 (2003) A327-M1194
43. Sanceau J., Boyd D.D., Seiki M., and Bauvois B. Interferons inhibit TNF-alpha-mediated MMP-9 activation via IRF1 binding competition with NF-kB. J Biol Chem 277 (2002) 35766-35775